A diagnostic challenge-First case of chronic lymphatic leukemia-associated necrotizing sweet syndrome.

CLL Sweet Syndrome necrotizing Sweet Syndrome necrotizing fasciitis

Journal

European journal of haematology
ISSN: 1600-0609
Titre abrégé: Eur J Haematol
Pays: England
ID NLM: 8703985

Informations de publication

Date de publication:
Apr 2024
Historique:
revised: 30 11 2023
received: 04 10 2023
accepted: 01 12 2023
pubmed: 18 12 2023
medline: 18 12 2023
entrez: 18 12 2023
Statut: ppublish

Résumé

Sweet syndrome, also known as acute febrile neutrophilic dermatosis, is a rare disorder typically characterized by the clinical triad including a sudden onset of fever, painful skin lesions, and neutrophilia. The histopathological findings are a dense neutrophilic infiltrate and oedema of the dermis and epidermis without evidence of a vasculitis. Besides treatment of the underlying cause, sweet syndrome is typically treated with high-dose corticosteroids leading to a relapse-free response in 70% of patients. However, if left unrecognized or untreated, the condition may lead to serious complications. Here, we report on the case of a 38-year-old patient in whom, under the assumption of the presence of necrotizing fasciitis, exarticulation of the right arm was performed. In the absence of pathogen detection and insufficient response to anti-infective therapies, the diagnosis of a sweet syndrome was assumed and, later, confirmed by an excellent response to high-dose administration of systematic glucocorticoids. The case emphasizes the need to be aware of this rare syndrome, which can be easily misdiagnosed due to its close resemblance to infection and stresses the need of further research to define distinct diagnostic tools.

Identifiants

pubmed: 38105522
doi: 10.1111/ejh.14153
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

650-653

Informations de copyright

© 2023 The Authors. European Journal of Haematology published by John Wiley & Sons Ltd.

Références

Joshi TP, Friske SK, Hsiou DA, Duvic M. New practical aspects of sweet syndrome. Am J Clin Dermatol. 2022;23(3):301-318. doi:10.1007/s40257-022-00673-4
Sanchez IM, Lowenstein S, Johnson KA, et al. Clinical features of neutrophilic dermatosis variants resembling necrotizing fasciitis. JAMA Dermatol. 2019;155(1):79-84. doi:10.1001/jamadermatol.2018.3890
Smith CR, Williams P. Sweet's syndrome in a patient with chronic lymphocytic leukaemia. BMJ Case Rep. 2017;2017. doi:10.1136/bcr-2017-220317
Heath MS, Ortega-Loayza AG. Insights into the pathogenesis of Sweet's syndrome. Front Immunol. 2019;10(MAR). doi:10.3389/fimmu.2019.00414
Hallek M, Cheson BD, Catovsky D, et al. Special report IwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. 2018 http://ashpublications.org/blood/article-pdf/131/25/2745/1465960/blood806398.pdf

Auteurs

Marie Anne-Catherine Neumann (MA)

Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.

Pascal Nieper (P)

Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.

Florian Simon (F)

Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.

Alexander Shimabukuro-Vornhagen (A)

Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.

Michael Hallek (M)

Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.

Jorge Garcia Borrega (J)

Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.

Classifications MeSH